Compare ASGN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASGN | CERT |
|---|---|---|
| Founded | 1985 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.1B |
| IPO Year | 1996 | 2020 |
| Metric | ASGN | CERT |
|---|---|---|
| Price | $35.72 | $6.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $51.20 | $12.22 |
| AVG Volume (30 Days) | 550.4K | ★ 3.3M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 2.60 | N/A |
| Revenue | ★ $3,980,400,000.00 | $418,838,000.00 |
| Revenue This Year | $3.26 | $5.05 |
| Revenue Next Year | $4.94 | $5.73 |
| P/E Ratio | $13.74 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $35.51 | $6.04 |
| 52 Week High | $65.51 | $15.38 |
| Indicator | ASGN | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 30.37 | 35.76 |
| Support Level | N/A | $6.04 |
| Resistance Level | $49.41 | $7.52 |
| Average True Range (ATR) | 1.71 | 0.36 |
| MACD | -0.33 | 0.03 |
| Stochastic Oscillator | 2.59 | 17.77 |
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.